News Conference News ESC 2013 Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation Caitlin E. Cox September 04, 2013
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis September 04, 2013
News Conference News ESC 2013 PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times September 03, 2013
News Conference News ESC 2013 CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis Yael L. Maxwell September 03, 2013
News Industry News Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System September 03, 2013
News Conference News ESC 2013 BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin Caitlin E. Cox September 03, 2013
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013